KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Deferred Taxes (2018 - 2024)

Vir Biotechnology's Deferred Taxes history spans 3 years, with the latest figure at -$2.6 million for Q4 2024.

  • For Q4 2024, Deferred Taxes fell 148.64% year-over-year to -$2.6 million; the TTM value through Dec 2024 reached -$3.6 million, changed N/A, while the annual FY2024 figure was -$2.9 million, 177.42% down from the prior year.
  • Deferred Taxes for Q4 2024 was -$2.6 million at Vir Biotechnology, down from $57000.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at $57000.0 in Q3 2024 and bottomed at -$2.6 million in Q4 2024.